Breaking News Instant updates and real-time market news.

XRAY

Dentsply Sirona

$60.75

0.24 (0.40%)

, PDCO

Patterson Companies

$39.05

-0.21 (-0.53%)

08:14
11/28/16
11/28
08:14
11/28/16
08:14

Credit Suisse to hold meetings and booth tours

Dental & Animal Health Meeting & Booth Tours will be held in New York on November 28.

XRAY

Dentsply Sirona

$60.75

0.24 (0.40%)

PDCO

Patterson Companies

$39.05

-0.21 (-0.53%)

DHR

Danaher

$79.56

0.4 (0.51%)

ZTS

Zoetis

PAHC

Phibro Animal Health

$28.00

-0.05 (-0.18%)

WOOF

VCA Inc.

$64.58

0.24 (0.37%)

  • 28

    Nov

  • 29

    Nov

  • 15

    Dec

XRAY Dentsply Sirona
$60.75

0.24 (0.40%)

09/22/16
09/22/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: Packaging Corp. (PKG) initiated with a Sell at Goldman. 2. Netlist (NLST) initiated with a Buy at B. Riley. 3. Weyerhaeuser (WY) initiated with a Conviction Buy at Goldman. 4. bluebird bio (BLUE) reinstated with a Buy at Roth Capital. 5. Dentsply Sirona (XRAY) initiated with a Neutral at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/01/16
MSCO
11/01/16
UPGRADE
MSCO
Overweight
Dentsply Sirona upgraded to Overweight from Equal Weight at Morgan Stanley
11/01/16
11/01/16
UPGRADE
Target $69

Overweight
Dentsply Sirona upgraded on growth, valuation at Morgan Stanley
As previously reported, Morgan Stanley upgraded Denstply Sirona to Overweight from Equal Weight and raised its price target to $69 from $65. Analyst Steve Beuchaw said Densply's relative valuation weakness positions the company for better performance despite negative dental market sentiment. He expects Dentsply's organic growth to accelerate in 2017 driven by digital dentistry adoption, a focus on commercial headcount, easing digital equipment comps, and revenue synergies. Beauchaw expects the company's double digit free cash flow growth potential to improve investor sentiment.
11/22/16
PIPR
11/22/16
NO CHANGE
PIPR
Patterson cancellation a positive for Dentsply, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien believes Patterson Companies (PDCO) cancelling its exclusive selling agreement with legacy Sirona products beyond September 2017 as positive for Dentsply Sirona (XRAY). The move is unsurprising given the changing industry dynamics, O'Brien tells investors in a research note. He points out that the initial exclusive agreement was established in 1998. Assuming Henry Schein (HSIC) starts selling legacy Sirona equipment, the cancellation is a positive for Dentsply as this will ultimately allow the company to increase cross-selling opportunities with those customers, O'Brien argues. He's been calling for a cancellation of the exclusive selling agreement with Patterson saying Dentsply has been adamant about realizing sales synergies through increased cross-selling opportunities. The analyst reiterates an Overweight rating on Dentsply with a $70 price target. Patterson in pre-market trading is down 17% to $39.20 after reporting a decline in North American dental consumables sales of 2.5%. Dentsply shares are down 2% to $58.40.
PDCO Patterson Companies
$39.05

-0.21 (-0.53%)

11/23/16
JPMS
11/23/16
NO CHANGE
Target $40
JPMS
Neutral
Patterson Companies price target lowered to $40 from $48 at JPMorgan
JPMorgan analyst Lisa Gill lowered her price target for Patterson Companies to $40 from $48 after the company reported Q2 earnings below her estimate and cut its FY17 earnings guidance. The analyst remains cautious on Patterson's outlook "given the lack of visibility into the timing of improvement on both sides of the business." She keeps a Neutral rating on the shares.
11/01/16
NRCS
11/01/16
NO CHANGE
NRCS
Amazon.com should partner with Patterson Companies, says Northcoast
Northcoast said Amazon.com (AMZN) has a strong interest in entering the dental market and has spent time and resources attempting to build relationships with manufacturers and distributors to gain product procurement, which so far has been unsuccessful. The firm's analyst said Patterson (PDCO) is aggressively trying to reinvent how dental distribution will occur in the future and is building a new IT backbone, making huge investments in technical service. Northcoast said Patterson is on a path to disrupt the industry and could accelerate this effort with a partnership with Amazon. The firm continues to view Patterson as undervalued, with out without Amazon, and recommends investors build positions at this time.
11/21/16
BARD
11/21/16
NO CHANGE
BARD
Outperform
Baird expects Amazon.com distribution announcement with Patterson
Following industry conversions, Baird analyst Jeff Johnson expects Patterson Companies (PDCO) to announce an Amazon.com (AMZN) distribution agreement tomorrow. What the analyst hadnt considered and is now hearing is that Amazon could fulfill orders placed through Patterson's order portal, lowering Patterson's fulfillment costs and given the company breathing room as it pursues DSO deals. Johnson rates Patterson a Neutral with a $48 price target.
DHR Danaher
$79.56

0.4 (0.51%)

11/15/16
BOFA
11/15/16
NO CHANGE
Target $93
BOFA
Buy
Danaher added to US 1 List at BofA/Merrill
BofA/Merrill analyst Derik de Bruin added Danaher to the US 1 List saying the company is one of the better positioned Life Sciences sector companies following the US election outcome. The analyst believes Danaher's end markets exposure to Water infrastructure spending, Dental and Product ID businesses, and increased aerospace and defense stand to benefit from the Republican sweep. Further, de Bruin said the Cepheid acquisition is a good strategic fit with its leading molecular diagnostics platform. The analyst reiterates his Buy rating and raised his price target to $93 from $89 on Danaher shares.
11/11/16
COWN
11/11/16
UPGRADE
Target $95
COWN
Outperform
Danaher upgraded to Outperform from Market Perform at Cowen
Cowen analyst Doug Schenkel upgraded Danaher to Outperform and raised his price target to $95 from $85. The analyst believes recent M&A will drive core revenue growth to 5% by 2020, and provides margin expansion opportunities, and recent downward revisions to consensu estimates makes 2016-2018 estimates beatable.
09/07/16
BERN
09/07/16
NO CHANGE
BERN
Danaher acquisition should be positive over the mid to long-term, says Bernstein
After Danaher (DHR) agreed to buy Cepheid (CPHD), Bernstein analyst Steven Winoker says that the deal was expensive. However, the analyst says that Cepheid has high recurring revenue, fast growth, and strong synergies with Danaher. Winoker thinks that the deal leaves Danaher well-positioned for growth over the medium to longer term. He keeps a $92 price target and Outperform rating on the stock.
10/12/16
EVER
10/12/16
NO CHANGE
Target $89
EVER
Buy
Danaher acquisition of Phenomenex highly attractive, says Evercore ISI
Evercore ISI analyst Ross Muken is not surprised by Danaher's (DHR) acquisition of Phenomenex saying it is one of the "great consumable assets that remained in Life Science Tools." Muken said the deal terms are "remarkably attractive" and estimates Danaher paid more than $700M for Phenomenex He said revenues are close to $200M, implying an EV/EBITDA multiple in the low to mid-teens, and ROIC north of 10% by year 5, and imply year 1 accretion of 3-5c, and 10-15c by year 5. Muken rates Danaher a Buy with an $89 price target on shares.
ZTS Zoetis

10/11/16
STFL
10/11/16
NO CHANGE
STFL
Zoetis outlook positive despite cattle headwinds, says Stifel
Stifel analyst Jonathan Block says that Zoetis is facing a number of headwinds in cattle, including difficult comps and unfavorable cattle and milk prices. However, he thinks the company will be boosted in Q4 and into fiscal 2017 by easing comps and its "competitive" vaccine offering. Block says that the outlook for the company's companion animal and swine offerings remain positive, and he thinks the company's EPS can beat expectations over the next 12-24 months. Block keeps a Buy rating on the shares.
09/29/16
BOFA
09/29/16
INITIATION
Target $60
BOFA
Buy
Zoetis reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Derik de Bruin restated coverage on Zoetis with a Buy and a $60 price target.
07/14/16
JEFF
07/14/16
NO CHANGE
JEFF
AbbVie remains Jefferies' Top Pick in Global Pharma
Jefferies analyst Jeffrey Holford says AbbVie (ABBV) remains his firm's Top Pick in Global Pharmaceuticals, followed by Eli Lilly (LLY), Novartis (NVS), GlaxoSmithKline (GSK) and Zoetis (ZTS). The analyst this morning upgraded GSK to Buy from Hold. Holford also remains positive on Roche (RHHBY), Abbott (ABT) and Pfizer (PFE). The analyst's least preferred names are Novo Nordisk (NVO), Johnson & Johnson (JNJ) and Merck (MRK). The Q2 earnings season offers "few clear beat and raise" stories and looks weakest for AstraZeneca (AZN) against preliminary consensus, Holford tells investors in a pre-earnings research note.
09/07/16
FBCO
09/07/16
NO CHANGE
FBCO
Progressive, U.S. Silica and Zoetis added to US Focus List at Credit Suisse
Credit Suisse added Progressive (PGR), U.S. Silica (SLCA) and Zoetis (ZTS) to the US Focus List and removed Allison Transmission (ALSN) from the US Focus List and Sealed Air (SEE) from the US Focus List and Global Focus List
PAHC Phibro Animal Health
$28.00

-0.05 (-0.18%)

04/19/16
MACQ
04/19/16
NO CHANGE
Target $23
MACQ
Neutral
Phibro Animal Health price target lowered to $23 from $31 at Macquarie
Macquarie analyst Matthew Brooks lowered his price target for Phibro Animal Health to $23 saying the potential Mecadox approval withdrawal highlights the risks to company's Medicated Feed Additives business. The analyst thinks the MFA business should trade on a lower target valuation multiple. He keeps a Neutral rating on Phibro.
11/10/16
GABE
11/10/16
DOWNGRADE
GABE
Hold
Phibro Animal Health downgraded to Hold from Buy at Gabelli
Gabelli analyst Kevin Kdera downgraded Phibro Animal Health to Hold following in-line Q1 results due to valuation.
11/11/16
MACQ
11/11/16
DOWNGRADE
MACQ
Underperform
Phibro Animal Health downgraded to Underperform from Neutral at Macquarie
11/11/16
MACQ
11/11/16
DOWNGRADE
Target $21
MACQ
Underperform
Phibro Animal Health downgraded to Underperform on MFA slowdown at Macquarie
As previously reported, Macquarie downgraded Phibro Animal Health to Underperform from Neutral and reduced its price target to $21. Analyst Matthew Brooks saying valuation is too high given the structurally challenged MFA business.
WOOF VCA Inc.
$64.58

0.24 (0.37%)

10/24/16
BNCH
10/24/16
INITIATION
Target $90
BNCH
Buy
VCA Inc. initiated with a Buy at Benchmark
Benchmark analyst Raymond Myers initiated VCA Inc with a Buy and a $90 price target.
02/04/16
FBCO
02/04/16
INITIATION
Target $63
FBCO
Outperform
VCA Inc. initiated with an Outperform at Credit Suisse
Credit Suisse analyst Erin Wilson initiated VCA Inc with an Outperform rating and a $63 price target.
09/29/16
BOFA
09/29/16
INITIATION
Target $78
BOFA
VCA Inc. reinstated with a with a Buy at BofA/Merrill
BofA/Merrill analyst Derik De Bruin reinstated VCA Inc. with a Buy and a $78 price target.
02/04/16
02/04/16
INITIATION

On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AT&T (T) initiated with a Buy at DA Davidson... Abaxis (ABAX) initiated with an Underperform at Credit Suisse... Aratana Therapeutics (PETX) initiated with an Outperform at Credit Suisse... Care.com (CRCM) initiated with an Equal Weight at Morgan Stanley... GCP Applied Technologies (GCP) initiated with a Buy at Jefferies... Heritage-Crystal Clean (HCCI) initiated with a Buy at Roth Capital... IDEXX (IDXX) initiated with an Outperform at Credit Suisse... Nexvet Biopharma (NVET) initiated with an Outperform at Credit Suisse... PetMed Express (PETS) initiated with an Underperform at Credit Suisse... Phibro Animal Health (PAHC) initiated with an Outperform at Credit Suisse... Pure Storage (PSTG) initiated with a Perform at Oppenheimer... SeaWorld (SEAS) initiated with a Neutral at Janney Capital... Seattle Genetics (SGEN) initiated with an Overweight at Barclays... VCA Inc. (WOOF) initiated with an Outperform at Credit Suisse... Verizon (VZ) initiated with a Neutral at DA Davidson... Zoetis (ZTS) initiated with an Outperform at Credit Suisse.

TODAY'S FREE FLY STORIES

MTRX

Matrix Service

$16.88

-0.575 (-3.30%)

18:32
04/27/17
04/27
18:32
04/27/17
18:32
Earnings
Matrix Service sees Q3 EPS (56c)-(49c), consensus 13c »

Sees Q3 revenue $250M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDC

Western Digital

$85.71

1.1 (1.30%)

, TOSBF

Toshiba, also use TOSYY

$1.97

-0.01 (-0.51%)

18:31
04/27/17
04/27
18:31
04/27/17
18:31
Hot Stocks
Western Digital on Toshiba chip sale: Evaluating 'full range' of alternatives »

Western Digital (WDC)…

WDC

Western Digital

$85.71

1.1 (1.30%)

TOSBF

Toshiba, also use TOSYY

$1.97

-0.01 (-0.51%)

TOSYY

Toshiba, also use TOSBF

$11.89

0.07 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

MBFI

MB Financial

$43.09

-0.37 (-0.85%)

18:24
04/27/17
04/27
18:24
04/27/17
18:24
Recommendations
MB Financial analyst commentary  »

MB Financial reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 23

    May

VRSN

VeriSign

$88.53

-0.31 (-0.35%)

18:21
04/27/17
04/27
18:21
04/27/17
18:21
Earnings
VeriSign raises FY17 revenue view to $1.145B-$1.16B from $1.138B-$1.158B »

Consenssus $1.15B. Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

RRC

Range Resources

$27.35

-0.26 (-0.94%)

18:21
04/27/17
04/27
18:21
04/27/17
18:21
Upgrade
Range Resources rating change  »

Range Resources upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

ISBC

Investors Bancorp

$14.53

-0.16 (-1.09%)

18:19
04/27/17
04/27
18:19
04/27/17
18:19
Earnings
Investors Bancorp reports Q1 EPS 16c, consensus 16c »

Reports Q1 loan loss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 15

    May

  • 06

    Jun

ALGN

Align Technology

$120.09

0.35 (0.29%)

, EHTH

eHealth

$11.74

0.23 (2.00%)

18:16
04/27/17
04/27
18:16
04/27/17
18:16
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Align…

ALGN

Align Technology

$120.09

0.35 (0.29%)

EHTH

eHealth

$11.74

0.23 (2.00%)

TRMB

Trimble

$32.62

0.28 (0.87%)

LPLA

LPL Financial

$38.52

-0.84 (-2.13%)

GOOG

Alphabet

$874.25

2.52 (0.29%)

GOOGL

Alphabet Class A

$891.44

2.3 (0.26%)

AMZN

Amazon.com

$918.38

9.09 (1.00%)

CERN

Cerner

$60.06

0.53 (0.89%)

CY

Cypress Semiconductor

$14.40

0.42 (3.00%)

VRTX

Vertex

$117.42

1.08 (0.93%)

RXDX

Ignyta

$8.75

-0.45 (-4.89%)

HON

Honeywell

$129.88

-0.22 (-0.17%)

ATHN

athenahealth

$121.45

1.6 (1.34%)

CLD

Cloud Peak

$3.53

-0.13 (-3.55%)

PCMI

PCM, Inc.

$30.15

0.1 (0.33%)

ELLI

Ellie Mae

$110.72

1.55 (1.42%)

ARAY

Accuray

$4.60

-0.2 (-4.17%)

FTNT

Fortinet

$40.42

0.52 (1.30%)

SBUX

Starbucks

$61.30

-0.26 (-0.42%)

BIDU

Baidu

$187.86

1.19 (0.64%)

TNDM

TNDM

FLEX

Flex

$16.02

-0.05 (-0.31%)

EXPE

Expedia

$136.20

0.45 (0.33%)

AFL

Aflac

$75.05

0.25 (0.33%)

MSFT

Microsoft

$68.27

0.44 (0.65%)

SRPT

Sarepta

$34.72

-0.14 (-0.40%)

TRXC

TransEnterix

$1.09

-0.01 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 28

    Apr

  • 28

    Apr

  • 01

    May

  • 02

    May

  • 02

    May

  • 03

    May

  • 03

    May

  • 04

    May

  • 08

    May

  • 09

    May

  • 09

    May

  • 10

    May

  • 10

    May

  • 10

    May

  • 10

    May

  • 15

    May

  • 16

    May

  • 16

    May

  • 17

    May

  • 17

    May

  • 22

    May

  • 23

    May

  • 24

    May

  • 30

    May

  • 30

    May

  • 31

    May

  • 01

    Jun

  • 06

    Jun

  • 08

    Jun

  • 08

    Jun

  • 20

    Jun

  • 20

    Jun

  • 21

    Jun

  • 21

    Jun

  • 22

    Jun

  • 22

    Jun

IBKC

Iberiabank

$79.35

-0.4 (-0.50%)

18:16
04/27/17
04/27
18:16
04/27/17
18:16
Earnings
Iberiabank reports Q1 non-GAAP EPS $1.02, consensus 98c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 08

    May

  • 09

    May

  • 15

    May

  • 17

    May

KRNY

Kearny Financial

$15.30

-0.05 (-0.33%)

18:15
04/27/17
04/27
18:15
04/27/17
18:15
Earnings
Kearny Financial reports Q3 EPS 5c, consensus 6c »

Reports Q3 NII $26.21M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$87.91

-0.22 (-0.25%)

18:11
04/27/17
04/27
18:11
04/27/17
18:11
Hot Stocks
Celanese increases prive of vinyl acetate-based emulsion in China »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STX

Seagate

$42.30

0.29 (0.69%)

, WDC

Western Digital

$85.71

1.1 (1.30%)

18:09
04/27/17
04/27
18:09
04/27/17
18:09
Hot Stocks
Breaking Hot Stocks news story on Seagate, Western Digital »

Seagate shares up 1.1%…

STX

Seagate

$42.30

0.29 (0.69%)

WDC

Western Digital

$85.71

1.1 (1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 08

    Jun

FTNT

Fortinet

$40.42

0.52 (1.30%)

18:09
04/27/17
04/27
18:09
04/27/17
18:09
Earnings
Fortinet raises FY17 EPS view to 89c-91c from 87c-89c, consensus 89c »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 08

    Jun

FTNT

Fortinet

$40.42

0.52 (1.30%)

18:07
04/27/17
04/27
18:07
04/27/17
18:07
Earnings
Fortinet sees Q2 EPS 19c-20c, consensus 19c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 08

    Jun

SIMO

Silicon Motion

$44.28

-0.26 (-0.58%)

18:06
04/27/17
04/27
18:06
04/27/17
18:06
Earnings
Silicon Motion sees FY17 revenue $556M-$612M, consensus $580.14M »

Sees FY17 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 01

    May

  • 02

    May

  • 03

    May

  • 04

    May

  • 09

    May

  • 15

    May

  • 23

    May

  • 30

    May

  • 30

    May

  • 01

    Jun

  • 01

    Jun

SIMO

Silicon Motion

$44.28

-0.26 (-0.58%)

18:06
04/27/17
04/27
18:06
04/27/17
18:06
Earnings
Silicon Motion sees Q2 revenue $134M-$140M, consensus $139.02M »

Sees Q2 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 01

    May

  • 02

    May

  • 03

    May

  • 04

    May

  • 09

    May

  • 15

    May

  • 23

    May

  • 30

    May

  • 30

    May

  • 01

    Jun

  • 01

    Jun

SIMO

Silicon Motion

$44.28

-0.26 (-0.58%)

18:04
04/27/17
04/27
18:04
04/27/17
18:04
Earnings
Silicon Motion reports Q1 adjusted EPS 70c, consensus 69c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 01

    May

  • 02

    May

  • 03

    May

  • 04

    May

  • 09

    May

  • 15

    May

  • 23

    May

  • 30

    May

  • 30

    May

  • 01

    Jun

  • 01

    Jun

MSFT

Microsoft

$68.27

0.44 (0.65%)

18:01
04/27/17
04/27
18:01
04/27/17
18:01
Hot Stocks
Microsoft sees CapEx growing in Q4 »

Says spent less CapEx in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 09

    May

CMCSA

Comcast

$39.59

0.8 (2.06%)

, CMCSK

Comcast

18:01
04/27/17
04/27
18:01
04/27/17
18:01
Hot Stocks
Comcast 'very pleased' with auction, says no current plans for acquired spectrum »

Comcast issued the…

CMCSA

Comcast

$39.59

0.8 (2.06%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

CYTR

CytRx

$0.68

-0.121 (-15.02%)

18:00
04/27/17
04/27
18:00
04/27/17
18:00
Syndicate
CytRx announces common stock offering, no amount given »

CytRx Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

PCMI

PCM, Inc.

$30.15

0.1 (0.33%)

18:00
04/27/17
04/27
18:00
04/27/17
18:00
Earnings
PCM, Inc. backs FY17 adjusted EPS view $2.00-$2.15, consensus $1.73 »

Backs FY17 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

PCMI

PCM, Inc.

$30.15

0.1 (0.33%)

17:59
04/27/17
04/27
17:59
04/27/17
17:59
Earnings
PCM, Inc. sees Q2 EPS 44c-49c, consensus 45c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

JNJ

Johnson & Johnson

$123.74

0.23 (0.19%)

17:58
04/27/17
04/27
17:58
04/27/17
17:58
Hot Stocks
Johnson & Johnson awarded $260.5M government contract »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 05

    May

  • 06

    Jun

PCMI

PCM, Inc.

$30.15

0.1 (0.33%)

17:58
04/27/17
04/27
17:58
04/27/17
17:58
Earnings
PCM, Inc. reports Q1 adjusted EPS 26c, consensus 14c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

WDC

Western Digital

$85.71

1.1 (1.30%)

17:57
04/27/17
04/27
17:57
04/27/17
17:57
Hot Stocks
Breaking Hot Stocks news story on Western Digital »

Western Digital reverses,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

MSFT

Microsoft

$68.27

0.44 (0.65%)

17:57
04/27/17
04/27
17:57
04/27/17
17:57
Hot Stocks
Microsoft says expects less FX impact in Q4 »

Comments from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 09

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.